{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:47:04Z","timestamp":1773974824188,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.yebeh.2020.107626","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T10:57:47Z","timestamp":1607511467000},"page":"107626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"PA","title":["Inconsistent reporting of drug\u2013drug interactions for hormonal contraception and antiepileptic drugs \u2013 Implications for reproductive health for women with epilepsy"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-7353","authenticated-orcid":false,"given":"Barbara M.","family":"Decker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5150-5995","authenticated-orcid":false,"given":"Emily K.","family":"Acton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison W.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2020.107626_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2016.08.021","article-title":"Counseling by epileptologists affects contraceptive choices of women with epilepsy","volume":"65","author":"Espinera","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2020.107626_b0010","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/ajmg.c.30306","article-title":"Influencing clinical practice regarding the use of antiepileptic medications during pregnancy: Modeling the potential impact on the prevalences of spina bifida and cleft palate in the United States","volume":"157","author":"Gilboa","year":"2011","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"key":"10.1016\/j.yebeh.2020.107626_b0015","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.seizure.2015.03.006","article-title":"Interactions between hormonal contraception and antiepileptic drugs: Clinical and mechanistic considerations","volume":"28","author":"Reimers","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107626_b0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2020.107626_b0025","article-title":"Clinical pharmacokinetic interactions between antiepiletic drugs and hormonal conraceptives","volume":"3","author":"Reddy","year":"2010","journal-title":"Exert Rev Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2020.107626_b0030","unstructured":"Elservier Inc. No Title. Clin Key CP 2019."},{"key":"10.1016\/j.yebeh.2020.107626_b0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1197\/jamia.M2808","article-title":"Tiering drug-drug interaction alerts by severity increases compliance rates","volume":"16","author":"Paterno","year":"2009","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.yebeh.2020.107626_b0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1331\/154434504773062582","article-title":"Concordance of severity ratings provided in four drug interaction compendia","volume":"44","author":"Abarca","year":"2004","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.yebeh.2020.107626_b0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5698\/1535-7511-17.1.25","article-title":"Contraceptive Methods, Seizures, and Antiepileptic Drugs: More Questions Than Answers","volume":"17","author":"Pack","year":"2017","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2020.107626_b0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.yebeh.2015.02.009","article-title":"Drug interactions involving antiepileptic drugs: Assessment of the consistency among three drug compendia and FDA-approved labels","volume":"44","author":"Ekstein","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"11","key":"10.1016\/j.yebeh.2020.107626_b0055","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/pds.4896","article-title":"Poor concordance among drug compendia for proposed interactions between enzyme\u2010inducing antiepileptic drugs and direct oral anticoagulants","volume":"28","author":"Acton","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.yebeh.2020.107626_b0060","unstructured":"Morbidity and Mortality Weekly Report Recommendations and Reports. 2016."},{"key":"10.1016\/j.yebeh.2020.107626_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.yebeh.2020.107626_b0070","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1212\/WNL.0b013e318259e1f9","article-title":"Progesterone vs placebo therapy for women with epilepsy: a randomized clinical trial","volume":"78","author":"Herzog","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2020.107626_b0075","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/acn3.50830","article-title":"Progesterone receptor activation regulates seizure susceptibility","volume":"6","author":"Shiono","year":"2019","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020308064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505020308064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:39:14Z","timestamp":1761503954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505020308064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":15,"alternative-id":["S1525505020308064"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107626","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inconsistent reporting of drug\u2013drug interactions for hormonal contraception and antiepileptic drugs \u2013 Implications for reproductive health for women with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2020.107626","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107626"}}